Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors

• Li-Song Zhang ,

  Contributed equally to this work with: Li-Song Zhang, Shu-Qing Wang

  Affiliation Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China

  ⨯
• Shu-Qing Wang ,

  Contributed equally to this work with: Li-Song Zhang, Shu-Qing Wang

  Affiliation Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China

  ⨯
• Wei-Ren Xu,

  Affiliation Tianjin Institute of Pharmaceutical Research (TIPR), Tianjin, China

  ⨯
• Run-Ling Wang ,

  * E-mail: wangrunling@tijmu.edu.cn (RLW); jfwang8113@sjtu.edu.cn (JFW)

  Affiliation Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China

  ⨯
• Jing-Fang Wang

  * E-mail: wangrunling@tijmu.edu.cn (RLW); jfwang8113@sjtu.edu.cn (JFW)

  Affiliations Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai Center for Bioinformation Technology, Shanghai, China

  ⨯